Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide

John F. Brady, Mong-Heng Wang, Jun Yan Hong, Fang Xiao, Yan Li, Jeong Sook H. Yoo, Shu M. Ning, Mao Jung Lee, Jon M. Fukuto, Jeanne M. Gapac, Chung S. Yang

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Diallyl sulfide (DAS) and other organosulfur compounds inhibit chemically induced carcinogenic and toxic responses in rodent model systems. A possible mechanism of action is the inhibition of the hepatic cytochrome P450IIE1-dependent bioactivation of the procarcinogens and protoxicants. Previous work showed competitive inhibition by DAS of N-nitrosodimethylamine (NDMA) demethylase activity in vitro, and a reduction in the microsomal level of P450IIE1 after in vivo treatment with DAS. The present studies demonstrated a time- and dose-dependent decrease of hepatic microsomal P450IIE1 activity, induction of P450IIB1 and pentoxyresorufin dealkylase activity, and moderate induction of ethoxyresorufin dealkylase activity by oral DAS treatment. DAS treatment elevated P450IIB1 mRNA but had no effect on P450IIE1 mRNA. Treatment with putative metabolites of DAS, diallyl sulfoxide and diallyl sulfone, led to similar modulations in monooxygenase activities, but the decrease of P450IIE1 activity by the sulfone occurred more rapidly. In studies in vitro, diallyl sulfone caused a metabolism-dependent inactivation of P450IIE1, but such inactivation was not observed with DAS or diallyl sulfoxide. The profile of microsomal testosterone metabolism after DAS treatment indicated an enhancement of P450IIB1-dependent 16β-hydroxylase activity, and a decrease in 6β-hydroxytestosterone production possibly related to a lower level of P450IIIA1 or IIIA2. When rats were subjected to a 48-hr fast and DAS treatment, the starvation-induced microsomal P450IIE1 level was decreased by DAS. Inhibition of hepatotoxicity due to exposure to P450IIE1 substrates, CCl4 and NDMA, by DAS was observed under a variety of treatment schedules.

Original languageEnglish (US)
Pages (from-to)342-354
Number of pages13
JournalToxicology and Applied Pharmacology
Volume108
Issue number2
DOIs
StatePublished - Apr 1991
Externally publishedYes

Fingerprint

Aryl Hydrocarbon Hydroxylases
Cytotoxicity
Rats
Modulation
Liver
Enzymes
Mixed Function Oxygenases
Metabolism
Hydroxytestosterones
allyl sulfide
Dimethylnitrosamine
Cytochrome P-450 CYP2E1
Messenger RNA
Sulfones
Cytochrome P-450 CYP1A1
Poisons
Cytochromes
Metabolites
Starvation
Testosterone

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide. / Brady, John F.; Wang, Mong-Heng; Hong, Jun Yan; Xiao, Fang; Li, Yan; Yoo, Jeong Sook H.; Ning, Shu M.; Lee, Mao Jung; Fukuto, Jon M.; Gapac, Jeanne M.; Yang, Chung S.

In: Toxicology and Applied Pharmacology, Vol. 108, No. 2, 04.1991, p. 342-354.

Research output: Contribution to journalArticle

Brady, JF, Wang, M-H, Hong, JY, Xiao, F, Li, Y, Yoo, JSH, Ning, SM, Lee, MJ, Fukuto, JM, Gapac, JM & Yang, CS 1991, 'Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide', Toxicology and Applied Pharmacology, vol. 108, no. 2, pp. 342-354. https://doi.org/10.1016/0041-008X(91)90123-V
Brady, John F. ; Wang, Mong-Heng ; Hong, Jun Yan ; Xiao, Fang ; Li, Yan ; Yoo, Jeong Sook H. ; Ning, Shu M. ; Lee, Mao Jung ; Fukuto, Jon M. ; Gapac, Jeanne M. ; Yang, Chung S. / Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide. In: Toxicology and Applied Pharmacology. 1991 ; Vol. 108, No. 2. pp. 342-354.
@article{d94035df0d504e9bbc225ba6fe868bde,
title = "Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide",
abstract = "Diallyl sulfide (DAS) and other organosulfur compounds inhibit chemically induced carcinogenic and toxic responses in rodent model systems. A possible mechanism of action is the inhibition of the hepatic cytochrome P450IIE1-dependent bioactivation of the procarcinogens and protoxicants. Previous work showed competitive inhibition by DAS of N-nitrosodimethylamine (NDMA) demethylase activity in vitro, and a reduction in the microsomal level of P450IIE1 after in vivo treatment with DAS. The present studies demonstrated a time- and dose-dependent decrease of hepatic microsomal P450IIE1 activity, induction of P450IIB1 and pentoxyresorufin dealkylase activity, and moderate induction of ethoxyresorufin dealkylase activity by oral DAS treatment. DAS treatment elevated P450IIB1 mRNA but had no effect on P450IIE1 mRNA. Treatment with putative metabolites of DAS, diallyl sulfoxide and diallyl sulfone, led to similar modulations in monooxygenase activities, but the decrease of P450IIE1 activity by the sulfone occurred more rapidly. In studies in vitro, diallyl sulfone caused a metabolism-dependent inactivation of P450IIE1, but such inactivation was not observed with DAS or diallyl sulfoxide. The profile of microsomal testosterone metabolism after DAS treatment indicated an enhancement of P450IIB1-dependent 16β-hydroxylase activity, and a decrease in 6β-hydroxytestosterone production possibly related to a lower level of P450IIIA1 or IIIA2. When rats were subjected to a 48-hr fast and DAS treatment, the starvation-induced microsomal P450IIE1 level was decreased by DAS. Inhibition of hepatotoxicity due to exposure to P450IIE1 substrates, CCl4 and NDMA, by DAS was observed under a variety of treatment schedules.",
author = "Brady, {John F.} and Mong-Heng Wang and Hong, {Jun Yan} and Fang Xiao and Yan Li and Yoo, {Jeong Sook H.} and Ning, {Shu M.} and Lee, {Mao Jung} and Fukuto, {Jon M.} and Gapac, {Jeanne M.} and Yang, {Chung S.}",
year = "1991",
month = "4",
doi = "10.1016/0041-008X(91)90123-V",
language = "English (US)",
volume = "108",
pages = "342--354",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide

AU - Brady, John F.

AU - Wang, Mong-Heng

AU - Hong, Jun Yan

AU - Xiao, Fang

AU - Li, Yan

AU - Yoo, Jeong Sook H.

AU - Ning, Shu M.

AU - Lee, Mao Jung

AU - Fukuto, Jon M.

AU - Gapac, Jeanne M.

AU - Yang, Chung S.

PY - 1991/4

Y1 - 1991/4

N2 - Diallyl sulfide (DAS) and other organosulfur compounds inhibit chemically induced carcinogenic and toxic responses in rodent model systems. A possible mechanism of action is the inhibition of the hepatic cytochrome P450IIE1-dependent bioactivation of the procarcinogens and protoxicants. Previous work showed competitive inhibition by DAS of N-nitrosodimethylamine (NDMA) demethylase activity in vitro, and a reduction in the microsomal level of P450IIE1 after in vivo treatment with DAS. The present studies demonstrated a time- and dose-dependent decrease of hepatic microsomal P450IIE1 activity, induction of P450IIB1 and pentoxyresorufin dealkylase activity, and moderate induction of ethoxyresorufin dealkylase activity by oral DAS treatment. DAS treatment elevated P450IIB1 mRNA but had no effect on P450IIE1 mRNA. Treatment with putative metabolites of DAS, diallyl sulfoxide and diallyl sulfone, led to similar modulations in monooxygenase activities, but the decrease of P450IIE1 activity by the sulfone occurred more rapidly. In studies in vitro, diallyl sulfone caused a metabolism-dependent inactivation of P450IIE1, but such inactivation was not observed with DAS or diallyl sulfoxide. The profile of microsomal testosterone metabolism after DAS treatment indicated an enhancement of P450IIB1-dependent 16β-hydroxylase activity, and a decrease in 6β-hydroxytestosterone production possibly related to a lower level of P450IIIA1 or IIIA2. When rats were subjected to a 48-hr fast and DAS treatment, the starvation-induced microsomal P450IIE1 level was decreased by DAS. Inhibition of hepatotoxicity due to exposure to P450IIE1 substrates, CCl4 and NDMA, by DAS was observed under a variety of treatment schedules.

AB - Diallyl sulfide (DAS) and other organosulfur compounds inhibit chemically induced carcinogenic and toxic responses in rodent model systems. A possible mechanism of action is the inhibition of the hepatic cytochrome P450IIE1-dependent bioactivation of the procarcinogens and protoxicants. Previous work showed competitive inhibition by DAS of N-nitrosodimethylamine (NDMA) demethylase activity in vitro, and a reduction in the microsomal level of P450IIE1 after in vivo treatment with DAS. The present studies demonstrated a time- and dose-dependent decrease of hepatic microsomal P450IIE1 activity, induction of P450IIB1 and pentoxyresorufin dealkylase activity, and moderate induction of ethoxyresorufin dealkylase activity by oral DAS treatment. DAS treatment elevated P450IIB1 mRNA but had no effect on P450IIE1 mRNA. Treatment with putative metabolites of DAS, diallyl sulfoxide and diallyl sulfone, led to similar modulations in monooxygenase activities, but the decrease of P450IIE1 activity by the sulfone occurred more rapidly. In studies in vitro, diallyl sulfone caused a metabolism-dependent inactivation of P450IIE1, but such inactivation was not observed with DAS or diallyl sulfoxide. The profile of microsomal testosterone metabolism after DAS treatment indicated an enhancement of P450IIB1-dependent 16β-hydroxylase activity, and a decrease in 6β-hydroxytestosterone production possibly related to a lower level of P450IIIA1 or IIIA2. When rats were subjected to a 48-hr fast and DAS treatment, the starvation-induced microsomal P450IIE1 level was decreased by DAS. Inhibition of hepatotoxicity due to exposure to P450IIE1 substrates, CCl4 and NDMA, by DAS was observed under a variety of treatment schedules.

UR - http://www.scopus.com/inward/record.url?scp=0026072030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026072030&partnerID=8YFLogxK

U2 - 10.1016/0041-008X(91)90123-V

DO - 10.1016/0041-008X(91)90123-V

M3 - Article

C2 - 2017758

AN - SCOPUS:0026072030

VL - 108

SP - 342

EP - 354

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -